vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Veralto (VLTO). Click either name above to swap in a different company.

Veralto is the larger business by last-quarter revenue ($1.4B vs $719.4M, roughly 2.0× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 17.9%, a 55.3% gap on every dollar of revenue. On growth, Veralto posted the faster year-over-year revenue change (6.8% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $170.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 6.8%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Veralto Corporation is an American technology company headquartered in Waltham, Massachusetts. It produces products related to water analytics, water treatment, marking and coding, and packaging and color.

DOC vs VLTO — Head-to-Head

Bigger by revenue
VLTO
VLTO
2.0× larger
VLTO
$1.4B
$719.4M
DOC
Growing faster (revenue YoY)
VLTO
VLTO
+3.7% gap
VLTO
6.8%
3.1%
DOC
Higher net margin
DOC
DOC
55.3% more per $
DOC
73.2%
17.9%
VLTO
More free cash flow
DOC
DOC
$187.0M more FCF
DOC
$357.0M
$170.0M
VLTO
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
6.8%
VLTO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
VLTO
VLTO
Revenue
$719.4M
$1.4B
Net Profit
$114.0M
$254.0M
Gross Margin
60.1%
Operating Margin
17.4%
23.8%
Net Margin
73.2%
17.9%
Revenue YoY
3.1%
6.8%
Net Profit YoY
2406.4%
12.9%
EPS (diluted)
$0.16
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
VLTO
VLTO
Q1 26
$1.4B
Q4 25
$719.4M
$1.4B
Q3 25
$705.9M
$1.4B
Q2 25
$694.3M
$1.3B
Q1 25
$702.9M
Q4 24
$698.0M
$1.3B
Q3 24
$700.4M
$1.3B
Q2 24
$695.5M
$1.3B
Net Profit
DOC
DOC
VLTO
VLTO
Q1 26
$254.0M
Q4 25
$114.0M
$239.0M
Q3 25
$-117.1M
$222.0M
Q2 25
$31.7M
$225.0M
Q1 25
$42.8M
Q4 24
$4.5M
$227.0M
Q3 24
$85.9M
$219.0M
Q2 24
$146.0M
$203.0M
Gross Margin
DOC
DOC
VLTO
VLTO
Q1 26
60.1%
Q4 25
60.1%
Q3 25
58.6%
60.0%
Q2 25
60.2%
60.4%
Q1 25
61.1%
Q4 24
60.3%
59.6%
Q3 24
60.0%
59.6%
Q2 24
60.6%
60.1%
Operating Margin
DOC
DOC
VLTO
VLTO
Q1 26
23.8%
Q4 25
17.4%
23.2%
Q3 25
9.2%
22.8%
Q2 25
5.7%
24.2%
Q1 25
7.7%
Q4 24
-2.2%
22.9%
Q3 24
14.1%
23.4%
Q2 24
22.3%
23.2%
Net Margin
DOC
DOC
VLTO
VLTO
Q1 26
17.9%
Q4 25
73.2%
17.0%
Q3 25
-16.6%
16.2%
Q2 25
4.6%
16.9%
Q1 25
6.1%
Q4 24
0.7%
16.9%
Q3 24
12.3%
16.7%
Q2 24
21.0%
15.8%
EPS (diluted)
DOC
DOC
VLTO
VLTO
Q1 26
$1.02
Q4 25
$0.16
$0.95
Q3 25
$-0.17
$0.89
Q2 25
$0.05
$0.90
Q1 25
$0.06
Q4 24
$0.02
$0.91
Q3 24
$0.12
$0.88
Q2 24
$0.21
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
VLTO
VLTO
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$7.5B
Total Assets
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
VLTO
VLTO
Q1 26
Q4 25
$467.5M
$1.8B
Q3 25
$91.0M
$1.6B
Q2 25
$89.4M
$1.2B
Q1 25
$70.6M
Q4 24
$119.8M
$1.1B
Q3 24
$180.4M
$1.3B
Q2 24
$106.9M
$1.0B
Total Debt
DOC
DOC
VLTO
VLTO
Q1 26
Q4 25
$9.8B
$2.7B
Q3 25
$9.1B
$2.7B
Q2 25
$9.0B
$2.6B
Q1 25
$8.9B
Q4 24
$8.7B
$2.6B
Q3 24
$8.6B
$2.6B
Q2 24
$8.6B
$2.6B
Stockholders' Equity
DOC
DOC
VLTO
VLTO
Q1 26
Q4 25
$7.5B
$2.8B
Q3 25
$7.6B
$2.7B
Q2 25
$7.9B
$2.3B
Q1 25
$8.2B
Q4 24
$8.4B
$2.0B
Q3 24
$8.6B
$2.0B
Q2 24
$8.8B
$1.7B
Total Assets
DOC
DOC
VLTO
VLTO
Q1 26
Q4 25
$20.3B
$7.4B
Q3 25
$19.6B
$7.2B
Q2 25
$19.8B
$6.6B
Q1 25
$19.8B
Q4 24
$19.9B
$6.4B
Q3 24
$20.0B
$6.3B
Q2 24
$20.2B
$5.9B
Debt / Equity
DOC
DOC
VLTO
VLTO
Q1 26
Q4 25
1.31×
0.94×
Q3 25
1.20×
1.01×
Q2 25
1.14×
1.14×
Q1 25
1.08×
Q4 24
1.04×
1.28×
Q3 24
1.00×
1.35×
Q2 24
0.98×
1.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
VLTO
VLTO
Operating Cash FlowLast quarter
$1.3B
$182.0M
Free Cash FlowOCF − Capex
$357.0M
$170.0M
FCF MarginFCF / Revenue
49.6%
12.0%
Capex IntensityCapex / Revenue
124.4%
0.8%
Cash ConversionOCF / Net Profit
10.99×
0.72×
TTM Free Cash FlowTrailing 4 quarters
$893.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
VLTO
VLTO
Q1 26
$182.0M
Q4 25
$1.3B
$270.0M
Q3 25
$315.0M
$339.0M
Q2 25
$363.5M
$157.0M
Q1 25
$279.4M
Q4 24
$1.1B
$285.0M
Q3 24
$318.2M
$224.0M
Q2 24
$316.2M
$251.0M
Free Cash Flow
DOC
DOC
VLTO
VLTO
Q1 26
$170.0M
Q4 25
$357.0M
$258.0M
Q3 25
$323.0M
Q2 25
$142.0M
Q1 25
Q4 24
$333.7M
$263.0M
Q3 24
$215.0M
Q2 24
$240.0M
FCF Margin
DOC
DOC
VLTO
VLTO
Q1 26
12.0%
Q4 25
49.6%
18.4%
Q3 25
23.6%
Q2 25
10.7%
Q1 25
Q4 24
47.8%
19.6%
Q3 24
16.4%
Q2 24
18.6%
Capex Intensity
DOC
DOC
VLTO
VLTO
Q1 26
0.8%
Q4 25
124.4%
0.9%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
Q4 24
105.6%
1.6%
Q3 24
0.7%
Q2 24
0.9%
Cash Conversion
DOC
DOC
VLTO
VLTO
Q1 26
0.72×
Q4 25
10.99×
1.13×
Q3 25
1.53×
Q2 25
11.48×
0.70×
Q1 25
6.52×
Q4 24
235.43×
1.26×
Q3 24
3.71×
1.02×
Q2 24
2.17×
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons